Australia - inglés - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 35661 - acetabulum prosthesis - freedom constrained acetabular cup all poly standard face liner component hip joint replacement prosthesis. made from uhmwpe with titanium ring. pre-assembled constraining ring for head and liner assembly in situ. all poly option for cemented applications. freedom constrained acetabular cup all poly standard face liner is intended for use as a component of a total hip prosthesis in primary and revision patients at high risk of dislocation due to a previous history of dislocation, bone loss, joint or soft tissue laxity, neuromuscular disease or intra-operative instability, and for whom all other options to constrained acetabular components have been considered.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 33175 - metallic femoral head prosthesis - chrome cobalt alloy femoral head designed for use only with freedom constrained acetabular liner. freedom constrained heads are available with type i and type 12/14 tapers with various neck lengths and are compatible with biomet?s modular femoral stems of the corresponding taper. biomet freedom constrained femoral heads are intended for use as a component of a total hip prosthesis in primary and revision patients with a high risk of dislocation due to a previous history, severe joint laxity, and/or palsy of surrounding musculature, bone loss, or intra-operative instability; for whom all other options to constrained acetabular components have been considered. the heads are designed to be used with either a biomet type 1 or type 12/14 femoral taper/stem, and freedom constrained acetabular liners.

Estados Unidos - inglés - NLM (National Library of Medicine)

co ltd jung min - sulfate ion (unii: 7is9n8kpmg) (sulfate ion - unii:7is9n8kpmg) - anti oxident, anti inflammatory take one capsule two times per day with water

Estados Unidos - inglés - NLM (National Library of Medicine)

homeocare laboratories - antimony trisulfide (unii: f79059a38u) (antimony trisulfide - unii:f79059a38u), cadmium sulfate (unii: 947unf3z6o) (cadmium cation - unii:t494fz4g8g), strychnos ignatii seed (unii: 1nm3m2487k) (strychnos ignatii seed - unii:1nm3m2487k), lobelia inflata (unii: 9pp1t3tc5u) (lobelia inflata - unii:9pp1t3tc5u), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), tobacco leaf (unii: 6yr2608rsu) (tobacco leaf - unii:6yr2608rsu), dieffenbachia seguine (unii: 01800c6e6b - temporarily relieves cravings for cigarettes & tobacco. 2 pump-sprays under the tongue, 3 times a day or as needed.

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - carbamazepine - oral tablet - 400mg

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - carbamazepine - oral tablet - 400mg

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - carbamazepine - oral tablet - 400mg

Estados Unidos - inglés - NLM (National Library of Medicine)

damon industries - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic, hand sanitizer hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available. - on children less than 2 months of age - on open skin wounds stop use and ask a doctor if irritation or rash occurs. these may be signs of a serious condition.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

max health limited - levetiracetam 1000mg;   - film coated tablet - 1000 mg - active: levetiracetam 1000mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose opadry white amb 84f58775 povidone purified talc - indicated for: - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation; - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; - add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme); and - add-on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

max health limited - levetiracetam 250mg;   - film coated tablet - 250 mg - active: levetiracetam 250mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose opadry blue amb 84f80803 povidone purified talc - indicated for: - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation; - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; - add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme); and - add-on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).